Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Umang-Vohra"

22 News Found

Cipla announces JV with Kemwell Biopharma and Manipal Education & Medical Group
News | January 09, 2024

Cipla announces JV with Kemwell Biopharma and Manipal Education & Medical Group

The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions


Cipla to further invest Rs. 42 crore in GoApptiv
Digitisation | December 17, 2023

Cipla to further invest Rs. 42 crore in GoApptiv

Expands patient reach to remotest towns by furthering investment in GoApptiv


Cipla Medpro South Africa to acquire Actor Pharma
News | September 05, 2023

Cipla Medpro South Africa to acquire Actor Pharma

This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market


Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr
News | May 13, 2023

Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr

Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023


Cipla EU to invest € 15 million in Ethris
News | December 30, 2022

Cipla EU to invest € 15 million in Ethris

Cipla and Ethris partner for the development of mRNA-based therapies


Cipla’s Indore plant joins the WEF's Lighthouse Network
Digitisation | October 12, 2022

Cipla’s Indore plant joins the WEF's Lighthouse Network

Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations


Cipla to further invest Rs 25.90 crore to acquire 22.02% stake in GoApptiv
Digitisation | June 28, 2022

Cipla to further invest Rs 25.90 crore to acquire 22.02% stake in GoApptiv

Strengthens investment in channels of the future to expand patient reach


Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa
Public Health | June 15, 2022

Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa

This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.


Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022
News | May 11, 2022

Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022

Cipla has reported consolidated financial results for the period ended March 31, 2022


Adopt digitisation & automation for business sustainability and quality excellence : CEOs
News | March 01, 2022

Adopt digitisation & automation for business sustainability and quality excellence : CEOs

Pankaj Patel, Chairman, Zydus Lifesciences; Umang Vohra, CEO, Cipla; G V Prasad, Co-Chairman, Dr Reddy's; Nilesh Gupta, MD, Lupin and Dilip Shanghvi, MD, Sun Pharmaceuticals sharing their vision to outline the roadmap for the industry.